Infectious Diseases: Sepsis; Pericarditis & Myocarditis; MRSA

$119.00$189.00

$189.00
$119.00
StreamingINCLUDED FREE

Topics and Objectives


Title: Emergency Medicine – Infectious Diseases: Sepsis; Pericarditis and Myocarditis; MRSA

Faculty: Andrew D. Perron, M.D., F.A.C.E.P., F.A.C.S.M

Original Release Date: July 1, 2017  Expiration Date: July 1, 2020

TOPIC 1: Early Goal Directed Therapy in Sepsis: Why All the Fuss?

Upon completion of this session, the participant should be able to:

  1. Determine the pathophysiology of sepsis and the sepsis syndrome.
  2. Evaluate the scope of the problem regarding effective management of sepsis in the ED.
  3. Appraise the principles of early goal-directed therapy in the treatment of sepsis.
  4. Employ the applicable “surviving sepsis” guidelines.
  5. Assess the potential gains that can be realized, as well as the pitfalls to avoid, in the management of sepsis utilizing early goal directed therapy.

TOPIC 2: Pericarditis and Myocarditis: How Can 2 Diseases Sound So Similar and Act So Differently?

Upon completion of this session, the participant should be able to:

  1. Illustrate the pathophysiology and clinical presentation of these two entities.
  2. Differentiate the potential pitfalls in the diagnosis and management of these diseases.
  3. Analyze the commonalities and differences of these closely related diseases.
  4. Recommend evidence-based work-up and treatment options for pericarditis and myocarditis.

TOPIC 3: Community Acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA): An Update

Upon completion of this session, the participant should be able to:

  1. Assess risk factors for CA-MRSA infection.
  2. Specify the best-evidence management of skin and soft-tissue infections in the era of drug resistance.
  3. Assess both pharmacologic and non-pharmacologic management strategies for this disease entity.
  4. Demonstrate familiarity with the latest treatment recommendations for CA-MRSA as directed by the CDC.


Total Cost: $
Category: Tag:

Title: Emergency Medicine – Infectious Diseases: Sepsis; Pericarditis and Myocarditis; MRSA

Faculty: Andrew D. Perron, M.D., F.A.C.E.P., F.A.C.S.M

Original Release Date: July 1, 2017  Expiration Date: July 1, 2020

TOPIC 1: Early Goal Directed Therapy in Sepsis: Why All the Fuss?

Upon completion of this session, the participant should be able to:

  1. Determine the pathophysiology of sepsis and the sepsis syndrome.
  2. Evaluate the scope of the problem regarding effective management of sepsis in the ED.
  3. Appraise the principles of early goal-directed therapy in the treatment of sepsis.
  4. Employ the applicable “surviving sepsis” guidelines.
  5. Assess the potential gains that can be realized, as well as the pitfalls to avoid, in the management of sepsis utilizing early goal directed therapy.

TOPIC 2: Pericarditis and Myocarditis: How Can 2 Diseases Sound So Similar and Act So Differently?

Upon completion of this session, the participant should be able to:

  1. Illustrate the pathophysiology and clinical presentation of these two entities.
  2. Differentiate the potential pitfalls in the diagnosis and management of these diseases.
  3. Analyze the commonalities and differences of these closely related diseases.
  4. Recommend evidence-based work-up and treatment options for pericarditis and myocarditis.

TOPIC 3: Community Acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA): An Update

Upon completion of this session, the participant should be able to:

  1. Assess risk factors for CA-MRSA infection.
  2. Specify the best-evidence management of skin and soft-tissue infections in the era of drug resistance.
  3. Assess both pharmacologic and non-pharmacologic management strategies for this disease entity.
  4. Demonstrate familiarity with the latest treatment recommendations for CA-MRSA as directed by the CDC.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

  • $119.00$189.00

    Critical Care: Aortic Emergencies; Acute Coronary Syndrome; High-Risk Abdomen

    View Product